SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Pearson plc (PSORF) trades at a trailing P/E of 28.0, forward P/E of 20.4. Trailing earnings yield is 3.57%, forward earnings yield 4.90%. PEG 0.55 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (60/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.55).
- Forward P/E 20.4 (down from trailing 28.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.55 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.57% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.90% as earnings recover.
Overall SharesGrow Score: 59/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PSORF
Valuation Multiples
P/E (TTM)28.0
Forward P/E20.4
PEG Ratio0.55
Forward PEG0.55
P/B Ratio0.00
P/S Ratio2.59
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.50
Forward EPS (Est.)$0.69
Book Value / Share$0.00
Revenue / Share$5.42
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.57%
Forward Earnings Yield4.90%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-2.87 |
$4.55B |
$-2.34B |
-51.3% |
| 2017 |
$0.50 |
$4.51B |
$406M |
9% |
| 2018 |
$0.76 |
$4.13B |
$588M |
14.2% |
| 2019 |
$0.34 |
$3.87B |
$264M |
6.8% |
| 2020 |
$0.41 |
$3.4B |
$330M |
9.7% |
| 2021 |
$0.23 |
$3.43B |
$177M |
5.2% |
| 2022 |
$0.33 |
$3.84B |
$242M |
6.3% |
| 2023 |
$0.53 |
$3.67B |
$378M |
10.3% |
| 2024 |
$0.63 |
$3.55B |
$434M |
12.2% |
| 2025 |
$0.50 |
$3.58B |
$334.95M |
9.4% |
